Natus Medical Inc

Find Ratings Reports
BABY : NASDAQ : Health Care
$40.10 -1.20 | -2.91%
Today's Range: 40.00 - 41.30
Avg. Daily Volume: 327,400
10/25/16 - 4:14 PM ET

Financial Analysis

NATUS MEDICAL INC's gross profit margin for the third quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. Even though sales decreased, the net income has increased, representing an increase to the bottom line. NATUS MEDICAL INC is extremely liquid. Currently, the Quick Ratio is 2.15 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.

During the same period, stockholders' equity ("net worth") has increased by 7.48% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit

Income Statement Q3 FY16 Q3 FY15
Net Sales ($mil)90.9194.58
EBITDA ($mil)17.4120.29
EBIT ($mil)12.9916.12
Net Income ($mil)13.1610.93

Balance Sheet Q3 FY16 Q3 FY15
Cash & Equiv. ($mil)106.5282.2
Total Assets ($mil)510.58469.88
Total Debt ($mil)0.00.0
Equity ($mil)409.26380.76

Profitability Q3 FY16 Q3 FY15
Gross Profit Margin66.1363.98
EBITDA Margin19.1521.44
Operating Margin14.2817.04
Sales Turnover0.730.79
Return on Assets7.988.47
Return on Equity9.9510.45
Debt Q3 FY16 Q3 FY15
Current Ratio2.983.36
Interest Expense0.00.0
Interest Coverage0.00.0

Share Data Q3 FY16 Q3 FY15
Shares outstanding (mil)32.9432.96
Div / share0.00.0
Book value / share12.4211.55
Institutional Own % n/a n/a
Avg Daily Volume328977.0315493.0


BUY. This stock's P/E ratio indicates a significant discount compared to an average of 45.75 for the Health Care Equipment & Supplies industry and a premium compared to the S&P 500 average of 24.75. Conducting a second comparison, its price-to-book ratio of 3.32 indicates a premium versus the S&P 500 average of 2.74 and a significant discount versus the industry average of 4.95. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. Upon assessment of these and other key valuation criteria, NATUS MEDICAL INC proves to trade at a discount to investment alternatives within the industry.

1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
BABY 33.31 Peers 45.75   BABY NA Peers 28.28

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

BABY is trading at a significant discount to its peers.


Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.

Ratio not available.

1 2 3 4 5
premium   discount
  Price to
1 2 3 4 5
premium   discount
BABY 22.88 Peers 24.23   BABY 0.76 Peers 0.89

Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.

BABY is trading at a valuation on par with its peers.


Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

BABY trades at a discount to its peers.

1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
BABY 3.32 Peers 4.95   BABY 2.47 Peers 21.75

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

BABY is trading at a significant discount to its peers.


Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, BABY is expected to significantly trail its peers on the basis of its earnings growth rate.

1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
BABY 3.64 Peers 9.56   BABY 1.14 Peers 18.83

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

BABY is trading at a significant discount to its industry on this measurement.


Lower. A sales growth rate that trails the industry implies that a company is losing market share.

BABY significantly trails its peers on the basis of sales growth



Latest Stock Upgrades/Downgrades